Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03863639 · ClinicalTrials.gov registry record
Changes in fMRI and Neurocognitive Function in Women With Pre-eclampsia
A clinical trial, sponsored by Duke University.
- Terminated
- Registry status
- 18
- Enrollment target
NCT03863639: Clinical Trial study, sponsored by Duke University.
NCT03863639 is a clinical trial that was terminated before completion, run by Duke University. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03863639 was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- 18 participants
- Enrollment target
Study Summary
This is a pilot study assessing fMRI changes and neurocognitive function in women with pre-eclampsia and healthy controls. Neurocognitive testing will be done during pregnancy and after delivery up to 2-6 weeks postpartum. fMRI will be done after delivery up to 2-6 weeks postpartum. The aims of this pilot study are therefore to 1) Determine the frequency and nature of co-morbid DTI white matter patency and fMRI functional connectivity changes in women with pre-eclampsia/eclampsia and 2) Determine the relationship between DTI white matter patency and fMRI functional connectivity changes to measurable alterations in cognitive function in this patient population. The aims of this pilot study are therefore to 1) Determine the frequency and nature of co-morbid DTI white matter patency and fMRI functional connectivity changes in women with pre-eclampsia/eclampsia and 2) Determine the relationship between DTI white matter patency and fMRI functional connectivity changes to measurable alterations in cognitive function in this patient population.
Primary Outcome
DTI white matter patency in women with pre-eclampsia/eclampsia.
Interventions
- DIAGNOSTIC_TEST Neuroimaging Procedures
- DIAGNOSTIC_TEST Neuropsychological Assessment Procedures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2014-07-07 |
| Est. Completion | 2022-04-13 |
Why NCT03863639 stopped before completion
NCT03863639 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Neuroimaging Procedures is the first listed.
NCT03863639 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03863639 about?
NCT03863639 is a clinical study titled "Changes in fMRI and Neurocognitive Function in Women With Pre-eclampsia". This is a pilot study assessing fMRI changes and neurocognitive function in women with pre-eclampsia and healthy controls. Neurocognitive testing will be done during pregnancy and after delivery up to 2-6 weeks postpartum. fMRI will be done after delivery up to 2-6 weeks postpartum. The aims of this...
What is the current status of trial NCT03863639?
This trial is currently terminated. The enrollment target is 18 participants. The study started on 2014-07-07. Estimated completion is 2022-04-13.
What interventions are being tested in trial NCT03863639?
The interventions under investigation include: Neuroimaging Procedures (DIAGNOSTIC_TEST), Neuropsychological Assessment Procedures (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03863639?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI